Sclerosis / hypoxia

PCP receptor ligands and the use thereof

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

FIELD OF THE INVENTION The invention is in the field of pharmaceutical compositions which are useful for the prevention and/or treatment of neurodegradation and other neuropathological conditions in animals. BACKGROUND OF THE INVENTION The amino acid L-glutamate is widely thought to act as a

PCP receptor ligands and the use thereof

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

FIELD OF THE INVENTION The invention is in the field of pharmaceutical compositions which are useful for the prevention and/or treatment of neurodegradation and other neuropathological conditions in animals. BACKGROUND OF THE INVENTION The amino acid L-glutamate is widely thought to act as a

Crystalline forms of tricyclic compound acid salt or hydrate thereof, and method for making thereof

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

TECHNICAL FIELD The present disclosure relates to novel crystalline acid salts of a tricyclic derivative or a hydrate thereof, and a production method thereof. BACKGROUND Drugs administered orally show medicinal effects through absorption, distribution, metabolism or elimination, and the intrinsic

Substituted 5-membered ring compounds and their use

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

This application is a U.S. National Stage application of co-pending PCT application PCT/GB2004/002755, filed Jun. 24, 2004, which claims the priority of Great Britain Patent Application No. 0315111.5, filed Jun. 27, 2003. These applications are incorporated herein by reference in their

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

BACKGROUND OF THE INVENTION This invention relates to N,N'-disubstituted guanidine analogues, and to compounds and pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods for treating any disease of the nervous system in

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

FIELD OF THE INVENTION This invention is in the field of medicinal chemistry. In particular, this invention relates to N,N'-disubstituted guanidine analogues, and to compounds and pharmaceutical composition comprising the same, which possess neuroprotective capability. This invention further relates

Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

FIELD OF THE INVENTION This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

FIELD OF THE INVENTION This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

FIELD OF THE INVENTION This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

FIELD OF THE INVENTION This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

FIELD OF THE INVENTION This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

FIELD OF THE INVENTION This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid

Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

FIELD OF THE INVENTION This invention relates to tri- and tetra-substituted guanidines, and to pharmaceutical compositions comprising the same, which possess neuroprotective capability. This invention further relates to methods involving the use of these compounds as excitatory amino acid

Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

This invention relates to novel branched adamantyl, noradamantyl aryl and aralkylpiperazines having serotonin 5-HT.sub.1A activity. More particularly, the present invention relates to compounds and methods using them to provide neuroprotection and prevent, inhibit or limit processes of

Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-HT1A activity

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

This invention relates to novel branched adamantyl, noradamantyl aryl and aralkylpiperazines having serotonin 5-HT.sub.1A activity. More particularly, the present invention relates to compounds and methods using them to provide neuroprotection and prevent, inhibit or limit processes of

sclerosis/hypoxia

PCP receptor ligands and the use thereof

PCP receptor ligands and the use thereof

Crystalline forms of tricyclic compound acid salt or hydrate thereof, and method for making thereof

Substituted 5-membered ring compounds and their use

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists

Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists

Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity

Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-HT1A activity

Najkompletnija baza ljekovitog bilja potpomognuta znanošću